Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Management of neurogenic bladder in patients with multiple sclerosis.
Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.
Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug.
Myopathy associated with Neuromyelitis Optica Spectrum Disorders.
Treatment of multiple sclerosis in Germany: an analysis based on claims data of more than 30,000 patients.
Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.
Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis.
Multiple Sclerosis treatment and infectious issues: Update 2013.
Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair.
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.
The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice.
Applications of optical coherence tomography in pediatric clinical neuroscience.
Ethyl-eicosapentaenoic acid ameliorates the clinical course of experimental allergic encephalomyelitis induced in dark agouti rats.
Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?
Implications of dietary salt intake for multiple sclerosis pathogenesis.
Exploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.
Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range.
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment.
Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages.
Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis.
Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis.
Microglia and neuroprotection.
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.
Time matters - Acute stress response and glucocorticoid sensitivity in early multiple sclerosis.
PSEUDOBULBAR AFFECT IN MULTIPLE SCLEROSIS PATIENTS.

Pages